BAFNA PHARMACEUTICALS LIMITED

Altre lingue Bafna Pharmaceuticals Limited

Azioni

BAFNAPH

INE878I01022

Prezzo di chiusura NSE India S.E. Altri mercati azionari 00:00:00 04/07/2024			Variaz. 5gg	Var. 1 gen.
91,72 ^INR	+4,99%		+21,53%	-0,30%

29/05	Bafna Pharmaceuticals Limited approva la nomina di A. Mohanachandran a Segretario aziendale e Responsabile della conformita	CI
29/05	Bafna Pharmaceuticals Limited riporta i risultati degli utili per il quarto trimestre terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Bafna Pharmaceuticals Limited Approves the Appointment of A. Mohanachandran as Company Secretary and Compliance Officer	29/05
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05
Bafna Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	29/05
Bafna Pharmaceuticals Limited Announces the Inauguration of New Quality Control Laboratory	26/04
Bafna Pharmaceuticals Limited Announces Resignation of Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	23/04
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Bafna Pharmaceuticals Resumes Commercial Production of Manufacturing Units in Chennai, India	11/12
Bafna Pharmaceuticals Limited Announces Commercial Production	08/12
Floods Disrupt Bafna Pharmaceuticals' Manufacturing Plant in Chennai, India	07/12
Bafna Pharmaceuticals Limited Announces Suspension of Chennai Production Activity Due to Impact of Michaung Cyclone	07/12
Bafna Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Bafna Pharmaceuticals Limited Announces Resignation of Kamlesh Kumar Babulal as Non-Executive Independent Director from the Board	23/09/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23
Bafna Pharmaceuticals Limited Approves Board Appointment	27/06/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23
Bafna Pharmaceuticals Limited Announces Appointment Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer	07/04/23
Bafna Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/02/23
Bafna Pharmaceuticals Limited Announces Resignation of Atul Sachdeva as Director	19/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Assicura e aumenta i rendimenti dei tuoi investimenti grazie all'accompagnamento dei nostri esperti

Assicurare i miei Investimenti

fermer